X chromosome inactivation in cervical cancer patients

Cancer Genetics and Cytogenetics

Volumn 146, Issue 1, 2003, Pages 73-76

  Kristiansen, Marianne ^a   Helland, Åslaug ^a   Kristensen, Gunnar B ^a   Olsen, Anne O ^b   Lønning, Per E ^c   Børresen Dale, Anne Lise ^a,d   Ørstavik, Karen Helene ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CHROMOSOME INACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EVALUATION; FEMALE; GENE FREQUENCY; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PRIORITY JOURNAL; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; X CHROMOSOME; X CHROMOSOME LINKAGE;

PAPILLOMAVIRUS;

EID: 0141453643     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00152-3     Document Type: Article

References (20)

1. Belmont J.W. Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet. 58:1996;1101-1108.
2. Puck J.M., Willard H.F. X inactivation in females with X-linked disease. N Engl J Med. 338:1998;325-328.
3. Brown C.J., Robinson W.P. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin Genet. 58:2000;353-363.
4. Busque L., Mio R., Mattioli J., Brais E., Blais N., Lalonde Y., Maragh M., Gilliland D.G. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood. 88:1996;59-65.
5. Christensen K., Kristiansen M., Hagen-Larsen H., Skytthe A., Bathum L., Jeune B., Andersen-Ranberg K., Vaupel J.W., Ørstavik K.H. X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood. 95:2000;2449-2451.
6. Kristiansen M., Langerød A., Knudsen G.P., Weber B.L., Børresen-Dale A.L., Ørstavik K.H. High frequency of skewed X inactivation in young breast cancer patients. J Med Genet. 39:2002;30-33.
7. International Agency for Research on Cancer (IARC). Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 64:1995;IARC, Lyon.
8. Hemminki K., Dong C., Vaittinen P. Familial risks in cervical cancer: is there a hereditary component? Int J Cancer. 82:1999;775-781.
9. Olsen A.O., Gjøen K., Sauer T., Ørstavik I., Næss O., Kierulf K., Sponland G., Magnus P. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer. 61:1995;312-315.
10. Helle S.I., Ekse D., Holly J.M.P., Lønning P.E. The IGF-system in healthy pre- and postmenstrual women: relations to demographic variables and sex-steroids. J Steroid Biochem Mol Biol. 81:2002;95-102.
11. Ørstavik K.H., Kristiansen M., Hagen-Larsen H., Knudsen G.P., Vaupel J.W., Bathum L., Naumova A.K., Christensen K. Increased skewing of X inactivation in elderly females may be determined by genes linked to the G6PD gene. Eur J Hum Genet. 9:(Suppl 1):2001;1417.
12. Allen R.C., Zoghbi H.Y., Mosely A.B., Rosenblatt H.M., Belmont J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 51:1992;1229-1239.
13. Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186.
14. Nathanson K.N., Wooster R., Weber B.L. Breast cancer genetics: what we know and what we need. Nat Med. 7:2001;552-556.
15. Helland Å, Børresen A.L., Kaern J., Rønningen K.S., Thorsby E. HLA antigens and cervical carcinoma. [Comment] Nature. 356:1992;23.
16. Helland Å, Olsen A.O., Gjøen K., Akselsen H.E., Sauer T., Magnus P., Børresen-Dale A.L., Rønningen K.S. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DAQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer. 76:1998;9-24.
17. Pisani P., Parkin D.M., Munoz N., Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev. 6:1997;387-400.
18. Sharp A., Robinson D., Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet. 107:2000;343-349.
19. Guo Z., Ponten F., Wilander E., Ponten J. Clonality of precursors of cervical cancer and their genetical links to invasive cancer. Mod Pathol. 13:2000;606-613.
20. Guo Z., Wu F., Asplund A., Hu X., Mazurenko N., Kisseljov F., Pontén J., Wilander E. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma. Mod Pathol. 14:2001;54-61.